Ablation of MLL3, MLL4, or both dramatically suppresses tumor growth and reduces tumor burden in immunocompetent mice and thus conferring a marked survival benefit to these mice (Fig. 2a–c). This evidence concerns the gene KMT2D and neoplasm.